Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
---|---|---|---|---|
HME1 | Ribociclib | 0.003162278 | 0.8652 | 0.01199 |
HME1 | Ribociclib | 0.003162278 | 0.7608 | 0.01043 |
HME1 | Ribociclib | 0.003162278 | 0.7722 | 0.01135 |
HME1 | Ribociclib | 0.01 | 0.7766 | 0.01517 |
HME1 | Ribociclib | 0.01 | 0.7390 | 0.05286 |
HME1 | Ribociclib | 0.01 | 0.6894 | 0.04108 |
HME1 | Ribociclib | 0.031622777 | 0.7487 | 0.00432 |
HME1 | Ribociclib | 0.031622777 | 0.7134 | 0.03636 |
HME1 | Ribociclib | 0.031622777 | 0.7597 | 0.04292 |
HME1 | Ribociclib | 0.1 | 0.5338 | 0.07653 |
HME1 | Ribociclib | 0.1 | 0.6188 | 0.05094 |
HME1 | Ribociclib | 0.1 | 0.7995 | 0.02807 |
HME1 | Ribociclib | 0.316227766 | 0.6077 | 0.07197 |
HME1 | Ribociclib | 0.316227766 | 0.5498 | 0.06944 |
HME1 | Ribociclib | 0.316227766 | 0.5675 | 0.08739 |
HME1 | Ribociclib | 1.0 | 0.5993 | 0.03599 |
HME1 | Ribociclib | 1.0 | 0.5368 | 0.02700 |
HME1 | Ribociclib | 1.0 | 0.5311 | 0.04479 |
HME1 | Ribociclib | 3.16227766 | 0.4741 | 0.09506 |
HME1 | Ribociclib | 3.16227766 | 0.4329 | 0.07544 |
HME1 | Ribociclib | 3.16227766 | 0.4655 | 0.10590 |
HME1 | Ribociclib | 10.0 | 0.2591 | 0.14606 |
HME1 | Ribociclib | 10.0 | 0.3352 | 0.12625 |
HME1 | Ribociclib | 10.0 | 0.2866 | 0.08069 |
HME1 | LY3023414 | 0.001 | 0.6083 | 0.06319 |